Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome*

  title={Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome*},
  author={Bradley C. Martin and Rahul Ganguly and Sandhya Pannicker and Feride H. Frech and Victoria Barghout},
  journal={Current Medical Research and Opinion},
  pages={771 - 780}
SUMMARY Background: Patients with irritable bowel syndrome are frequent users of the health care system. Design and methods: This retrospective matched case-control study assessed the economic impact of irritable bowel syndrome on the Medicaid program by comparing the health care utilization and expenditures of Medicaid patients with irritable bowel syndrome in California and North Carolina with age-, sex-, and race-matched control groups without the syndrome. Results: Average annual Medicaid… 

Use of health care resources and cost of care for adults with constipation.

A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation.

A large variation in attributable direct and indirect costs and drivers of these costs was observed and future research should refine burden of illness estimates to subtypes so that estimates associated with IBS-C and CC are differentiated.

Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.

Considering a conservative estimate of 2,736,700 Italian adults affected by the syndrome, the minimum costs due to IBS in Italy - likely underestimated - range from 6 to 8 billion euro per year.

Incremental Direct Expenditure of Treating Asthma in the United States

  • S. KambleM. Bharmal
  • Medicine, Political Science
    The Journal of asthma : official journal of the Association for the Care of Asthma
  • 2009
The prevalence of asthma among U.S. children and adults and its associated incremental expenditures, the annual direct medical expenditure attributable to asthma treatment is estimated at approximately $37.2 billion in 2007 U.s. dollars.

Review article: epidemiology and quality of life in functional gastrointestinal disorders

  • L. Chang
  • Medicine, Psychology
    Alimentary pharmacology & therapeutics
  • 2004
The health‐related quality of life appears to improve in treatment responders, or correlates with symptom improvement, with at least some treatment modalities studied in functional gastrointestinal disorders, but further studies are needed.


The clinical and economic implications of chronic constipation (CC) and irritable bowel syndrome (IBS) and their negative impact on quality of life are considerable and similarities and differences in epidemiology, diagnostic criteria, predominant symptoms, and treatment are addressed.



The economic consequences of irritable bowel syndrome: a US employer perspective.

Irritable bowel syndrome is a significant financial burden on the employer that arises from an increase in direct and indirect costs compared with the control group.

Costs of Care for Irritable Bowel Syndrome in Managed Care

Charges for asthma patients reflected the impact of an exacerbation of their asthma, whereas charges for IBS patients remained elevated throughout the 12-month period, peaking only slightly at the time of the diagnosis.

Costs of care for irritable bowel syndrome patients in a health maintenance organization

Patients with IBS show sustained increases in health care costs relative to population controls for both lower GI services and care unrelated to lower GI problems, however, the majority of the excess resulted from medical care not directly related to lowerGI problems.

Review article: irritable bowel syndrome

Irritable bowel syndrome is the most common disease diagnosed by gastroenterologists and affects about 20% of all people at any one time; the illness has a large economic impact on health‐care utilization and absenteeism.

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Multivariate statistical analyses suggest that gastrointestinal disorders, psychiatric disorders, and nongastrointestinal somatic disorders are distinct disorders and not manifestations of a common somatization disorder, but their strong comorbidity suggests a common feature important to their expression, which is most likely psychological.